We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+17.63%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$232M
AUM Growth
+$16.4M
Cap. Flow
-$8.14M
Cap. Flow %
-3.5%
Top 10 Hldgs %
43.79%
Holding
71
New
6
Increased
12
Reduced
32
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 77.54%
2 Energy 3.54%
3 Communication Services 1.89%
4 Real Estate 1.41%
5 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEO icon
1
NeoGenomics
NEO
$1.96B
$16.7M 7.19%
2,032,635
-6,353
-0.3% -$53.3K
ATRC icon
2
AtriCure
ATRC
$1.92B
$14.7M 6.33%
929,876
+7,286
+0.8% +$112K
AKRX
3
DELISTED
Akorn Inc
AKRX
$14.3M 6.17%
525,548
-189
-0% -$5.6K
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$9.09M 3.91%
723,882
+23,033
+3% +$231K
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$8.68M 3.74%
391,169
-5,122
-1% -$96.2K
LHCG
6
DELISTED
LHC Group LLC
LHCG
$8.22M 3.54%
223,000
-3,943
-2% -$158K
HSTM icon
7
HealthStream
HSTM
$819M
$8.06M 3.47%
292,043
+86,745
+42% +$2.24M
HBIO icon
8
Harvard Bioscience
HBIO
$27.5M
$7.68M 3.31%
282,551
+8,531
+3% +$237K
TLGT
9
DELISTED
Teligent, Inc
TLGT
$7.57M 3.26%
99,608
-1,145
-1% -$90.9K
ARRY
10
DELISTED
Array Biopharma Inc
ARRY
$6.66M 2.87%
986,242
+431,401
+78% +$1.67M
NXTM
11
DELISTED
NxStage Medical Inc.
NXTM
$6.26M 2.69%
250,386
-3,727
-1% -$86.9K
OPCH icon
12
Option Care Health
OPCH
$3.45B
$6.12M 2.64%
529,690
+6,669
+1% +$71.9K
OFIX icon
13
Orthofix Medical
OFIX
$477M
$5.87M 2.53%
137,212
+7,467
+6% +$333K
AMED
14
DELISTED
Amedisys
AMED
$5.34M 2.3%
112,604
-8,174
-7% -$408K
ENZ
15
DELISTED
Enzo Biochem, Inc.
ENZ
$5.33M 2.3%
1,047,732
-317,231
-23% -$1.89M
KTWO
16
DELISTED
K2M Group Holdings, Inc
KTWO
$4.89M 2.11%
275,178
-6,797
-2% -$114K
SPNC
17
DELISTED
Spectranetics Corp
SPNC
$4.87M 2.1%
194,011
-4,208
-2% -$98.2K
CYNA
18
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$4.76M 2.05%
118,349
-70,228
-37% -$1.73M
MDCO
19
DELISTED
Medicines Co
MDCO
$4.76M 2.05%
126,024
+135
+0.1% +$5.09K
BLUE
20
DELISTED
bluebird bio
BLUE
$4.58M 1.97%
5,214
+38
+0.7% +$27.5K
MODN
21
DELISTED
MODEL N, INC.
MODN
$4.39M 1.89%
395,166
-1,986
-0.5% -$23.3K
PETX
22
DELISTED
Aratana Therapeutics, Inc.
PETX
$4.38M 1.89%
467,743
-217,178
-32% -$1.8M
VCYT icon
23
Veracyte
VCYT
$3.7B
$4.37M 1.88%
573,779
+27,758
+5% +$157K
SAGE
24
DELISTED
Sage Therapeutics
SAGE
$4.33M 1.86%
+94,037
New +$3.83M
LGND icon
25
Ligand Pharmaceuticals
LGND
$5.76B
$4.2M 1.81%
66,007
-1,511
-2% -$111K

Similar funds

First Light Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, First Light Asset Management held 71 positions worth $232M, up 7.6% from $216M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

First Light Asset Management withdrew a net $8.14M in Q3 2016, closing 3 positions and reducing 32 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $4.87M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 74% a quarter earlier, followed by Energy and Communication Services.

Against the trend, First Light Asset Management opened a new position in Sage Therapeutics worth $4.33M.

  • First Light Asset Management's largest Q3 2016 buy was Sage Therapeutics: 94,037 shares worth $4.33M.
  • First Light Asset Management added most to HealthStream in Q3 2016, an estimated $2.24M increase.
  • First Light Asset Management's biggest Q3 2016 reduction was LeMaitre Vascular, cutting an estimated $3.55M.
  • First Light Asset Management fully exited Envision Healthcare Holdings Inc in Q3 2016, selling an estimated $4.87M.
  • First Light Asset Management's ten largest holdings make up 44% of its $232M portfolio in Q3 2016.
  • First Light Asset Management opened 6 new positions and closed 3 in Q3 2016.
  • First Light Asset Management's portfolio value rose 7.6% quarter-over-quarter to $232M.

Based on First Light Asset Management's 13F filing for Q3 2016, filed 15 Nov 2016.